Altos Labs
PrivateLast Round
VC Round
Jan 19, 2022
Est. Valuation
$6.33B
Company Overview
Altos Labs is a biotechnology company focused on cellular rejuvenation programming to develop innovative medical solutions that aim to restore cell health and resilience, allowing clients to reverse disease, injury, and disabilities.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altos Labs Comparables
Compare Altos Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NewLimit | 87% | |
| Retro | 86% | |
| Life Biosciences | 81% |
Altos Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 19, 2022 |
Key People
Founding team and executive leadership
Altos Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altitude Life Science Ventures | VC Round |
| ARCH Venture Partners | VC Round |
| Bezos Expeditions | VC Round |
| ARCH Venture Partners | VC Round |
| General Catalyst | VC Round |
| Foresite Capital | VC Round |
| Mubadala Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Virtual Cell team won the Generalist prize in the ARC Virtual Cell Challenge.
- Jan 1, 2026
Ranked for the second consecutive year on the Forbes 2026 list.
Recent news
Latest coverage and updates
- attends_eventJul 30, 2026
Altos Labs, Inc. attended event VivaTech 2026 on Jul 30th '26.
Altos Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessAppears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about Altos Labs's valuation, stock price, and market status.
Is Altos Labs a public or private company?
Altos Labs is a private company.
What is the current stock price of Altos Labs?
Altos Labs is a private company with no public stock price. No recent secondary market data is available.
How much is Altos Labs worth (valuation)?
Altos Labs's valuation is estimated at $6.3B based on funding round data.
Can I buy Altos Labs stock?
Altos Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Altos Labs's last funding round?
Altos Labs's most recent funding round was Seed on January 19, 2022.
Who are the main investors in Altos Labs?
Key investors in Altos Labs include Altitude Life Science Ventures, Bezos Expeditions, ARCH Venture Partners, Foresite Capital, Mubadala Capital.
Will Altos Labs IPO soon?
No public IPO plans have been announced for Altos Labs.
How can I track Altos Labs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Altos Labs's secondary market activity and sign up for updates.